China Cardiac Rhythm Management Devices Market Outlook to 2033 - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD) and Others

Description

GlobalData's "China Cardiac Rhythm Management Devices Market Outlook to 2033" is a comprehensive databook report, covering key market data on the China Cardiac Rhythm Management Devices market. The databook report provides value (USD), volume (units) and average prices (USD) - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD) and Others.

The China Cardiac Rhythm Management Devices Market report provides key information and data on -

Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
2023 company share and distribution share data for Cardiac Rhythm Management Devices Market.
Global corporate-level profiles of key companies operating within the China Cardiac Rhythm Management Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

China Cardiac Rhythm Management Devices is segmented as follows -

Cardiac Resynchronisation Therapy (CRT)
Pacemakers
Implantable Cardioverter Defibrillators (ICD)
Implantable Loop Recorders (ILR)

Reasons to Buy

China Cardiac Rhythm Management Devices Market report helps you to develop -

Business strategies by identifying the key market segments poised for strong growth in the future.
Market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
Understand the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Product Code: GDME0195CCDB

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 What Is This Report About?
2.2 Cardiac Rhythm Management Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report

3 Cardiac Rhythm Management Devices Market, China

3.1 Cardiac Rhythm Management Devices Market, China, Revenue ($m), 2018-2033
- 3.1.1 Cardiac Resynchronisation Therapy (CRT) Market, China, Revenue ($m), by Segment, 2018-2033
- 3.1.2 Implantable Cardioverter Defibrillators (ICD) Market, China, Revenue ($m), by Segment, 2018-2033
- 3.1.3 Pacemakers Market, China, Revenue ($m), by Segment, 2018-2033
3.2 Cardiac Rhythm Management Devices Market, China, Volume (Units), 2018-2033
- 3.2.1 Cardiac Resynchronisation Therapy (CRT) Market, China, Volume (Units), by Segment, 2018-2033
- 3.2.2 Implantable Cardioverter Defibrillators (ICD) Market, China, Volume (Units), by Segment, 2018-2033
- 3.2.3 Pacemakers Market, China, Volume (Units), by Segment, 2018-2033
3.3 Cardiac Rhythm Management Devices Market, China, Average Price ($), 2018-2033
3.4 Cardiac Rhythm Management Devices Market, China, Distribution Share by Revenue ($m), 2023
3.5 Cardiac Rhythm Management Devices Market, China, Company Share by Revenue ($m), 2023

4 Overview of Key Companies in China, Cardiac Rhythm Management Devices Market

4.1 Medtronic Plc
- 4.1.1 Company Overview
4.2 Abbott Laboratories
- 4.2.1 Company Overview
4.3 Boston Scientific Corp
- 4.3.1 Company Overview
4.4 MicroPort Scientific Corp
- 4.4.1 Company Overview
4.5 Biotronik SE & Co KG
- 4.5.1 Company Overview

5 Cardiac Rhythm Management Devices Market Pipeline Products

6 Financial Deals Landscape

6.1 Debt Offerings
- 6.1.1 MicroPort Scientific to Raise USD220 Million in Public Offering of 5.75% Convertible Bonds Due 2028
6.2 Venture Financing
- 6.2.1 Shenyang Shenda Endoscope Raises Funds through Series C Financing

7 Recent Developments

7.1 Corporate Communications
- 7.1.1 Nov 20, 2023: Concord Medical Schedules 2023 Annual Meeting of Shareholders
- 7.1.2 Nov 10, 2023: Microport Appointment of Director
7.2 Financial Announcements
- 7.2.1 May 13, 2024: Stereotaxis Reports 2024 First Quarter Financial Results
- 7.2.2 Sep 22, 2023: Concord Medical Reports Financial Results for the First Half of 2023
- 7.2.3 Sep 21, 2023: Microport Scientific Corp. Announces 2023 Interim Report
7.3 Strategy And Business Planning
- 7.3.1 Jun 20, 2023: Shenzhen Mindray Bio-Medical Electronics Receives an Additional 510(k) Clearance for M11 Diagnostic Ultrasound System

8 Appendix

8.1 Research Methodology
- 8.1.1 Coverage
- 8.1.2 Secondary Research
- 8.1.3 Primary Research
- 8.1.4 Market Modeling and Forecasting
- 8.1.5 Company Share Analysis
- 8.1.6 Distribution Share Analysis
- 8.1.7 Benchmarking
8.2 GlobalData Consulting
8.3 Contact Us
8.4 Disclaimer